GMO Research & AI Yönetim

Yönetim kriter kontrolleri 2/4

GMO Research & AI's CEO is Shinichi Hosokawa, appointed in Sep 2006, has a tenure of 18.17 years. directly owns 5.12% of the company’s shares, worth ¥211.34M. The average tenure of the management team and the board of directors is 8.7 years and 8.7 years respectively.

Anahtar bilgiler

Shinichi Hosokawa

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	18.2yrs
CEO sahipliği	5.1%
Yönetim ortalama görev süresi	8.7yrs
Yönetim Kurulu ortalama görev süresi	8.7yrs

Son yönetim güncellemeleri

Recent updates

Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings Quality

Aug 22

GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than Expected

Aug 07

CEO

Shinichi Hosokawa (51 yo)

18.2yrs

Görev süresi

Mr. Shinichi Hosokawa has been Chief Executive Officer and President at GMO Research, Inc since September 2006 and served as its General Manager of Internal Audit Office since January 2008. Mr. Hosokawa ha...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Shinichi Hosokawa	CEO, President & Director	18.2yrs	Veri yok	5.12% ¥ 211.3m
Takenori Mori	MD, CFO	3.8yrs	Veri yok	0.20% ¥ 8.1m
Tetsuya Hongo	Senior MD of Business Development Headquarters & Innovation HQ	8.7yrs	Veri yok	0.27% ¥ 11.2m
Kenichiro Ando	GM of Global System Division	8.7yrs	Veri yok	0.29% ¥ 12.1m
Yukiya Nagata	Chief Revenue Officer	no data	Veri yok	0.061% ¥ 2.5m

8.7yrs

Ortalama Görev Süresi

47yo

Ortalama Yaş

Deneyimli Yönetim: 3695's management team is seasoned and experienced (8.7 years average tenure).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Shinichi Hosokawa	CEO, President & Director	18.7yrs	Veri yok	5.12% ¥ 211.3m
Takenori Mori	MD, CFO	4.7yrs	Veri yok	0.20% ¥ 8.1m
Tetsuya Hongo	Senior MD of Business Development Headquarters & Innovation HQ	8.7yrs	Veri yok	0.27% ¥ 11.2m
Kenichiro Ando	GM of Global System Division	8.7yrs	Veri yok	0.29% ¥ 12.1m
Yukiya Nagata	Chief Revenue Officer	2.7yrs	Veri yok	0.061% ¥ 2.5m
Masashi Yasuda	Director	8.7yrs	Veri yok	Veri yok
Masatoshi Kumagai	Executive Chairman	22.6yrs	Veri yok	Veri yok
Masaji Hashimoto	Independent Outside Director	10.7yrs	Veri yok	Veri yok
Masatoshi Hamatani	Outside Corporate Auditor	10.7yrs	Veri yok	Veri yok
Hideyuki Matsui	Corporate Auditor	1.8yrs	Veri yok	Veri yok

8.7yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 3695's board of directors are considered experienced (8.7 years average tenure).

GMO Research & AI Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

GMO Research, Inc., Annual General Meeting, Mar 18, 2024

GMO Research, Inc., Annual General Meeting, Mar 22, 2023

No independent directors

No independent directors

GMO Research, Inc., Annual General Meeting, Mar 18, 2022

GMO Research, Inc., Annual General Meeting, Mar 19, 2021

Recent updates

GMO Research & AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings Quality

Second quarter 2024 earnings released: JP¥12.24 loss per share (vs JP¥11.64 profit in 2Q 2023)

GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than Expected

Investor sentiment deteriorates as stock falls 21%

GMO Research & AI, Inc. to Report Q2, 2024 Results on Aug 06, 2024

First quarter 2024 earnings released: EPS: JP¥56.31 (vs JP¥82.69 in 1Q 2023)

GMO Research, Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: JP¥188 (vs JP¥218 in FY 2022)

GMO Research, Inc., Annual General Meeting, Mar 18, 2024

GMO Research, Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024

Upcoming dividend of JP¥115 per share at 4.0% yield

Third quarter 2023 earnings released: EPS: JP¥38.59 (vs JP¥44.12 in 3Q 2022)

GMO Research, Inc. to Report Q3, 2023 Results on Nov 06, 2023

New major risk - Earnings quality

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: JP¥11.64 (vs JP¥43.51 in 2Q 2022)

GMO Research, Inc. to Report Q2, 2023 Results on Aug 03, 2023

First quarter 2023 earnings released: EPS: JP¥82.69 (vs JP¥107 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)

Investor sentiment deteriorates as stock falls 15%

Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)

GMO Research, Inc., Annual General Meeting, Mar 22, 2023

Upcoming dividend of JP¥116 per share

GMO Research, Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023

No independent directors

Third quarter 2022 earnings released: EPS: JP¥44.12 (vs JP¥28.82 in 3Q 2021)

GMO Research, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: JP¥43.51 (vs JP¥14.11 in 2Q 2021)

GMO Research, Inc. to Report Q2, 2022 Results on Aug 04, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

GMO Research, Inc. to Report Q1, 2022 Results on May 09, 2022

First quarter 2022 earnings released: EPS: JP¥107 (vs JP¥64.39 in 1Q 2021)

No independent directors

GMO Research, Inc., Annual General Meeting, Mar 18, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥73.53 per share

Third quarter 2021 earnings released: EPS JP¥28.82 (vs JP¥25.76 in 3Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥64.39 (vs JP¥19.01 in 1Q 2020)

Investor sentiment improved over the past week

GMO Research, Inc. to launch new service brand “MO Lite”

GMO Research, Inc., Annual General Meeting, Mar 19, 2021

Full year 2020 earnings released: EPS JP¥107 (vs JP¥83.74 in FY 2019)

New 90-day low: JP¥1,645

GMO Research, Inc. to Report Q3, 2020 Results on Nov 06, 2020

GMO Research, Inc. to Report Q2, 2020 Results on Aug 07, 2020

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş